The Europe Plasma Fractionation Market is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028.
Europe Plasma Fractionation Market Introduction
The Europe plasma fractionation market encompasses key regional markets, including Germany, France, the UK, Spain, Italy, and the rest of Europe. Europe holds a significant share of the global plasma fractionation market and is projected to witness strong growth over the forecast period. This market growth is primarily driven by an aging population, increasing application of immunoglobulins for the treatment of chronic conditions, a rising prevalence of immune and bleeding disorders, and a growing demand for plasma-derived therapies in disease management.
The increasing geriatric population and the expanding therapeutic use of immunoglobulins in areas such as neurology, hematology, autoimmune diseases, and rare genetic disorders are expected to further boost market growth in the region. Additionally, several companies across Europe are ramping up research and development efforts to innovate and launch advanced plasma-based therapies.
The clinical approach to treating chronic diseases—such as neurological, hematological, and respiratory disorders—has evolved across European healthcare systems. The COVID-19 pandemic significantly influenced medical practices, leading to a shift in priorities toward managing critically ill patients and delaying routine treatment for other conditions. As a result, diagnostic and therapeutic procedures for several disorders were disrupted.
However, the pandemic also highlighted the therapeutic potential of plasma-based treatments. Various research organizations redirected their focus toward understanding and combating COVID-19. For example, the National Agency for Medicines and Health Products Safety of France (ANSM) approved the use of immune plasma therapy for critically ill patients, while the European Commission endorsed the emergency use of convalescent plasma in managing severe cases. These developments have had a mixed impact on the market—positively contributing to awareness and use of plasma therapies, but also temporarily diverting resources from other plasma-related RD and treatments.
In summary, while the COVID-19 pandemic created short-term disruptions in the treatment landscape for chronic disorders, it also spurred new interest and investment in plasma therapies. With the normalization of healthcare services and renewed focus on a broader range of diseases, the plasma fractionation market in Europe is expected to grow steadily in the coming years.
Europe Plasma Fractionation Market Segmentation
Europe Plasma Fractionation Market -By Product
- Immunoglobulin
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other
Europe Plasma Fractionation Market - By Application
- Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Others
Europe Plasma Fractionation Market - By End User
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Europe Plasma Fractionation Market - By Country
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Europe Plasma Fractionation Market - Company Profiles
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
Europe Plasma Fractionation Market Strategic Insights
Strategic insights for the Europe Plasma Fractionation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Europe Plasma Fractionation Market Regional Insights
The geographic scope of the Europe Plasma Fractionation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics Semiconductor; Aerospace Defense; Automotive Transportation; Energy Power; Healthcare; Manufacturing Construction; Food Beverages; Chemicals Materials; and Technology, Media, Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
